|
Molecular mechanisms of prostate cancer metastasis
|
5R01CA183929-04
|
$366,000
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
tDCS for Increasing Exercise Adherence in Individuals with Elevated Depressive Symptoms
|
5R21CA214102-02
|
$154,969
|
|
ABRANTES, ANA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
Genotype and Imaging Phenotype Biomarkers in Lung Cancer
|
5U01CA190234-04
|
$659,886
|
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
Genetic Dissection of Acute Myeloid Leukemia.
|
5R01CA169784-05
|
$355,993
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Personalized vaccine for patients with AML
|
5R01CA212649-02
|
$721,179
|
|
AVIGAN, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Radiolabeled FASN Inhibitors for PET Imaging
|
5R21CA213157-02
|
$176,883
|
|
BABICH, JOHN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Biophotonics to Couple Pancreatic with Upper GI Screening via Ultrathin Endoscopy
|
5R01CA183101-04
|
$620,486
|
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
DNA damage signaling to immune checkpoints
|
5R01CA204173-02
|
$376,715
|
|
BAKKENIST, CHRISTOPHER
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Catch and Release Immunotoxins: CAR-Bombs for Cancer
|
5R01CA204192-02
|
$360,914
|
|
BALTHASAR, JOSEPH
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Contribution of development and age to breast cancer etiology
|
5R01CA190980-04
|
$569,421
|
|
BARCELLOS-HOFF, MARY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Developing a Decision Aid for Adolescent and Young Adult Female Cancer Survivors Considering Future Family-Building after Treatment
|
5R03CA212924-02
|
$82,500
|
|
BENEDICT, CATHERINE
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
|
Role of KDM5A in pRB-mediated differentiation
|
5R01CA211095-02
|
$372,740
|
|
BENEVOLENSKAYA, ELIZAVETA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Investigating the role of the small GTPase RIT1 in lung adenocarcinoma
|
5R00CA197762-04
|
$249,000
|
|
BERGER, ALICE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Targeting Wnt signaling to overcome PARP inhibitor resistance in ovarian cancer
|
5R00CA194318-04
|
$249,001
|
|
BITLER, BENJAMIN
|
UNIVERSITY OF COLORADO DENVER
|
|
Intraoperative Polarization-Sensitive OCT for Assessing Breast Tumor Margins
|
5R01CA213149-02
|
$475,541
|
|
BOPPART, STEPHEN
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
Leukocyte telomere length in bladder cancer survivors: Diet and exercise trial
|
5R21CA212628-02
|
$203,580
|
|
BOVBJERG, DANA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Targeting HuR to improve a synthetic lethal therapy for pancreatic cancer
|
5R01CA212600-02
|
$372,748
|
|
BRODY, JONATHAN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Role of the macrophage derived XL313 epitope in angiogenesis and tumor growth
|
5R01CA196739-02
|
$356,850
|
|
BROOKS, PETER
|
MAINE MEDICAL CENTER
|
|
Center for Native Population Health Disparities
|
1P50CA148110-01
|
$1,911,941
|
$19,119
|
BUCHWALD, DEDRA
|
UNIVERSITY OF WASHINGTON
|
|
Randomized Trial of Workplace Interventions to Improve Health of Alaska Natives
|
5R01CA126620-04
|
$319,291
|
$319,291
|
BUCHWALD, DEDRA
|
UNIVERSITY OF WASHINGTON
|
|
USP7 inhibitors for the treatment of multiple myeloma
|
5R01CA211681-02
|
$504,721
|
|
BUHRLAGE, SARA
|
DANA-FARBER CANCER INST
|
|
Molecular Evaluation of Targeted Therapies in Lymphoid Malignancies
|
5R01CA183444-05
|
$501,285
|
|
BYRD, JOHN
|
OHIO STATE UNIVERSITY
|
|
Mechanisms of inv(16) acute myeloid leukemia
|
5R01CA204979-02
|
$436,263
|
|
CASTILLA, LUCIO
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Therapeutic approaches to ER mutant breast cancer
|
5R01CA204999-02
|
$392,078
|
|
CHANDARLAPATY, SARAT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Identification of DNA methylation markers for risk of metastasis in localized pro
|
5R01CA181242-04
|
$594,195
|
|
CHAO, CHUN
|
KAISER FOUNDATION RESEARCH INSTITUTE
|
|
Cancer Targeting through Drug Conjugates
|
5R21CA198684-02
|
$167,774
|
|
CHENG, JIANJUN
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
Targeting the Kinome in Neurofibromatosis type 1
|
5R01CA142928-09
|
$434,625
|
|
CHERNOFF, JONATHAN
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
A new class of CSF-1R radioligands for monitoring glioblastoma progression and therapy
|
5R21CA205564-02
|
$171,060
|
|
CHIN, FREDERICK
|
STANFORD UNIVERSITY
|
|
K-Ras plasma membrane interactions: a tractable therapeutic target
|
5R00CA188593-04
|
$249,000
|
|
CHO, KWANG-JIN
|
WRIGHT STATE UNIVERSITY
|
|
Physiological role of the TNKS-PI31 dependent proteasome regulation
|
5R00CA190658-04
|
$207,995
|
|
CHO, PAK
|
UNIVERSITY OF PENNSYLVANIA
|
|
Secondary Prevention through Surveillance and Intervention
|
5R01CA208273-02
|
$660,057
|
|
CHODOSH, LEWIS
|
UNIVERSITY OF PENNSYLVANIA
|
|
Elucidating the Regulation and Function of the NF1 tumor suppressor
|
5R01CA111754-13
|
$316,635
|
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Signal transduction regulating tumor cell dissemination
|
5R01CA150344-30
|
$396,625
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
High-frequency Irreversible Electroporation (H-FIRE) combinatorial GBM treatment
|
5R01CA213423-02
|
$359,874
|
|
DAVALOS, RAFAEL
|
VIRGINIA POLYTECHNIC INST AND ST UNIV
|
|
Novel Theranostics for Pancreatic Cancer
|
5R01CA174861-05
|
$319,031
|
|
DAVYDOVA, JULIA
|
UNIVERSITY OF MINNESOTA
|
|
Cancer Cell Intrinsic Interferon-I pathway Activation by Fractionated Radiation
|
5R01CA201246-03
|
$387,731
|
|
DEMARIA, SANDRA
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Modulation of BAK in Lung Cancer Therapeutics
|
5R01CA200905-02
|
$356,850
|
|
DENG, XINGMING
|
EMORY UNIVERSITY
|
|
Regulatory non-Smad signaling in TGF-b-induced epithelial-mesenchymal transition
|
5R01CA136690-10
|
$356,625
|
|
DERYNCK, RIK
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Merkel cell polyomavirus T antigens in tumorigenesis
|
5R01CA189352-04
|
$354,563
|
|
DLUGOSZ, ANDRZEJ
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Characterizing the landscape of resistance and persistence mechanisms in CML
|
5R01CA065823-22
|
$329,175
|
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
APPLYING ERROR-CORRECTED SEQUENCING TO DETECT MINIMAL RESIDUAL IN THE AAML 1031 STUDY
|
5R01CA211711-02
|
$352,587
|
|
DRULEY, TODD
|
WASHINGTON UNIVERSITY
|
|
Targeting the kinome in K-ras driven colorectal cancers
|
5R01CA211670-02
|
$418,613
|
|
DUNCAN, JAMES
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
A Multilevel Intervention to Increase the Participation of African Americans in Prostate Cancer Clinical Trials
|
5R01CA200718-03
|
$665,635
|
|
EGGLY, SUSAN
|
WAYNE STATE UNIVERSITY
|
|
Analytical Methods for Automated Quality Control of Cancer PET Imaging Tracer - [F-18]FDG
|
5R44CA192499-03
|
$1,198,721
|
|
ELIZAROV, ARKADIJ
|
TRACE-ABILITY, INC.
|
|
Preclinical Analyses of NAD Kinase as a Redox Vulnerability for the Treatment of Pancreatic Cancer
|
5R01CA211176-02
|
$362,569
|
|
ELSEA, SARAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Oncogenic Events in Thyroid Neoplasia
|
5R01CA072597-19
|
$428,500
|
|
FAGIN, JAMES
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Passive and active targeting of unnatural chemokine fusions for cancer immunotherapies
|
1F32CA220990-01
|
$61,174
|
|
FANG, TAO
|
BOSTON CHILDREN'S HOSPITAL
|
|
The Effectiveness, Safety, and Costs of Guideline-Concordant Lung Nodule Care
|
5R01CA207375-02
|
$621,132
|
|
FARJAH, FARHOOD
|
UNIVERSITY OF WASHINGTON
|
|
Academic-Industrial Partnership for Translation of PET/TRUS Guided Intervention
|
5R01CA204254-02
|
$135,982
|
|
FEI, BAOWEI
|
EMORY UNIVERSITY
|
|
Mediastinal Lymph Node Identification in Lung Cancer using NIR Fluorescent VATS
|
5R01CA207500-02
|
$743,574
|
|
FRANGIONI, JOHN
|
CURADEL, LLC
|
Total relevant funding to Arctic for this search: $684,462
|